NASDAQ : BRTX
BioRestorative Therapies, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 1.4003 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 1.78M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
BioRestorative Therapies, Inc. (BRTX) reported revenue of 357.87K USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 357.87K | 359.70K | 401.00K | 145.80K | 119.80K | 46.00K |
| Cost of Revenue | 28.32K | 23.84K | 28.07K | |||
| Gross Profit | 329.55K | 335.86K | 372.93K | 145.80K | 119.80K | 46.00K |
| Selling, General & Admin | 5.18M | 5.89M | 5.22M | 11.33M | 15.58M | 25.62M |
| Research & Development | 9.37M | 10.09M | 6.71M | 4.03M | 3.51M | 729.06K |
| Operating Expenses | 14.55M | 15.98M | 11.93M | 15.37M | 19.09M | 26.35M |
| Operating Income | -14.23M | -15.65M | -11.56M | -15.22M | -18.97M | -26.31M |
| Interest Expense | -1.82M | |||||
| Interest & Investment Income | 171.08K | 266.21K | 616.08K | 552.29K | 11.65K | |
| Other Non Operating Income (Expenses) | 3.00M | 1.14M | 1.96M | 4.25M | 5.49M | |
| EBT Excluding Unusual Items | -11.06M | -14.24M | -8.98M | -10.42M | -13.47M | -28.12M |
| Other Unusual Items | 250.00K | -16.18M | ||||
| Pretax Income | -11.06M | -14.24M | -8.98M | -10.42M | -13.22M | -44.30M |
| Net Income | -11.06M | -14.24M | -8.98M | -10.42M | -13.22M | -44.30M |
| Net Income to Common | -11.06M | -14.24M | -8.98M | -10.42M | -13.22M | -44.30M |
| Shares Outstanding (Basic) | 566.79K | 449.66K | 388.20K | 210.92K | 180.89K | 59.39K |
| Shares Outstanding (Diluted) | 566.79K | 449.66K | 388.20K | 210.92K | 180.89K | 59.39K |
| EPS (Basic) | -19.51 | -31.67 | -23.13 | -49.39 | -73.09 | -746.01 |
| EPS (Diluted) | -19.51 | -31.67 | -23.13 | -49.39 | -73.09 | -746.01 |
| Free Cash Flow | -11.90M | -10.91M | -8.34M | -6.60M | -6.18M | -3.36M |
| Free Cash Flow Per Share | -20.99 | -24.25 | -21.48 | -31.30 | -34.16 | -56.59 |
| Gross Margin | 92.09% | 93.37% | 93.00% | 100.00% | 100.00% | 100.00% |
| Operating Margin | -3,975.00% | -4,350.05% | -2,881.60% | -10,439.49% | -15,838.08% | -57,191.03% |
| Profit Margin | -3,089.55% | -3,959.40% | -2,239.25% | -7,145.20% | -11,036.98% | -96,311.51% |
| Free Cash Flow Margin | -3,324.57% | -3,031.70% | -2,078.94% | -4,527.61% | -5,157.20% | -7,305.58% |
| EBITDA | -14.01M | -15.44M | -11.37M | -15.06M | -18.85M | -26.22M |
| D&A For EBITDA | 210.60K | 209.99K | 189.06K | 165.74K | 120.55K | 89.11K |
| EBIT | -14.23M | -15.65M | -11.56M | -15.22M | -18.97M | -26.31M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 3.11M | 1.51M | 547.89K | 884.38K | 1.71M | 21.03M |
| Short-Term Investments | 479.35K | 1.44M | 10.18M | 10.18M | 13.04M | |
| Cash & Short-Term Investments | 3.59M | 2.95M | 10.73M | 11.07M | 14.75M | 21.03M |
| Receivables | 13.30K | 15.50K | 188.40K | 19.30K | 16.00K | 5.00K |
| Prepaid Expenses | 194.38K | 158.92K | 212.98K | 305.23K | 363.08K | 436.18K |
| Other Current Assets | 9.52K | 10.25K | ||||
| Total Current Assets | 3.80M | 3.14M | 11.14M | 11.39M | 15.13M | 21.47M |
| Property, Plant & Equipment | 328.81K | 358.77K | 362.94K | 507.50K | 502.76K | 395.80K |
| Other Intangible Assets | 511.76K | 534.20K | 623.95K | 713.69K | 803.44K | 589.74K |
| Long-Term Deferred Charges | 49.81K | 148.70K | ||||
| Total Assets | 4.64M | 4.08M | 12.28M | 12.61M | 16.43M | 22.45M |
| Accounts Payable | 666.90K | 1.34M | 483.07K | 189.39K | 170.90K | 50.83K |
| Accrued Expenses | 884.45K | 796.69K | 719.00K | 711.69K | 130.07K | 134.97K |
| Short-Term Debt | 28.77K | 42.28K | ||||
| Current Portion of Long-Term Debt | 58.97K | |||||
| Current Portion of Leases | 162.32K | 139.33K | 119.06K | |||
| Other Current Liabilities | 34.52K | 1.54M | 2.55M | 1.54M | 5.54M | |
| Total Current Liabilities | 1.61M | 3.72M | 3.75M | 2.61M | 5.98M | 363.82K |
| Long-Term Debt | 191.03K | |||||
| Long-Term Leases | 162.32K | 301.64K | ||||
| Total Liabilities | 1.61M | 3.72M | 3.75M | 2.61M | 6.14M | 856.50K |
| Common Stock | 2.55K | 887.00 | 692.00 | 471.00 | 369.00 | 353.00 |
| Additional Paid-In Capital | 175.10M | 170.26M | 164.20M | 156.69M | 146.56M | 155.73M |
| Retained Earnings | -172.08M | -169.92M | -155.68M | -146.70M | -136.28M | -134.15M |
| Total Common Equity | 3.03M | 342.76K | 8.52M | 9.99M | 10.28M | 21.58M |
| Shareholders' Equity | 3.03M | 356.74K | 8.53M | 10.00M | 10.29M | 21.60M |
| Total Liabilities & Equity | 4.64M | 4.08M | 12.28M | 12.61M | 16.43M | 22.45M |
| Total Debt | 28.77K | 42.28K | 162.32K | 301.64K | 670.70K | |
| Net Cash (Debt) | 3.56M | 2.91M | 10.73M | 10.90M | 14.45M | 20.36M |
| Net Cash Per Share | 6.29 | 6.47 | 27.65 | 51.70 | 79.87 | 342.77 |
| Filing Date Shares Outstanding | 1.27M | 1.27M | 375.24K | 338.50K | 188.38K | 181.33K |
| Total Common Shares Outstanding | 1.27M | 443.81K | 346.00K | 235.35K | 183.89K | 176.02K |
| Working Capital | 2.19M | -586.03K | 7.40M | 8.78M | 9.15M | 21.10M |
| Book Value Per Share | 2.38 | 0.77 | 24.62 | 42.45 | 55.88 | 122.61 |
| Tangible Book Value | 2.51M | -191.44K | 7.89M | 9.28M | 9.47M | 20.99M |
| Tangible Book Value Per Share | 1.97 | -0.43 | 22.81 | 39.42 | 51.51 | 119.26 |
| Machinery | 1.05M | 995.82K | 889.63K | 737.25K | 519.31K | |
| Construction In Progress | 64.13K | |||||
| Leasehold Improvements | 342.05K | 342.05K | 342.05K | 342.05K | 304.66K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -11.06M | -14.24M | -8.98M | -10.42M | -13.22M | -44.30M |
| Depreciation & Amortization | 210.60K | 209.99K | 189.06K | 165.74K | 120.55K | 89.11K |
| Other Amortization | 1.13M | |||||
| Stock-Based Compensation | 1.61M | 3.33M | 2.81M | 7.78M | 12.61M | 23.11M |
| Other Operating Activities | -3.15M | -1.39M | -2.28M | -4.48M | -5.44M | 16.32M |
| Change in Accounts Receivable | 11.70K | 172.90K | -169.10K | -3.30K | -11.00K | 12.00K |
| Change in Accounts Payable | 41.09K | 839.52K | 293.68K | 18.49K | 120.08K | -68.02K |
| Change in Unearned Revenue | -150.00K | |||||
| Change in Other Net Operating Assets | 668.09K | 297.05K | -95.93K | 500.14K | -94.93K | 380.71K |
| Operating Cash Flow | -11.82M | -10.79M | -8.23M | -6.43M | -5.91M | -3.33M |
| Capital Expenditures | -79.67K | -116.07K | -106.19K | -171.04K | -265.22K | -30.66K |
| Sale (Purchase) of Intangibles | -175.00K | |||||
| Investment in Securities | 7.58M | 9.01M | 620.72K | 3.42M | -12.96M | |
| Investing Cash Flow | 7.50M | 8.90M | 514.53K | 3.25M | -13.40M | -30.66K |
| Long-Term Debt Issued | 250.00K | |||||
| Total Debt Issued | 250.00K | |||||
| Net Debt Issued (Repaid) | 250.00K | |||||
| Issuance of Common Stock | 7.01M | 3.14M | 8.12M | 2.35M | 21.07M | |
| Other Financing Activities | -808.18K | -282.62K | -744.06K | |||
| Financing Cash Flow | 6.20M | 2.85M | 7.38M | 2.35M | 21.32M | |
| Net Cash Flow | 1.88M | 963.30K | -336.49K | -829.39K | -19.31M | 17.96M |
| Free Cash Flow | -11.90M | -10.91M | -8.34M | -6.60M | -6.18M | -3.36M |
| Free Cash Flow Margin | -3,324.57% | -3,031.70% | -2,078.94% | -4,527.61% | -5,157.20% | -7,305.58% |
| Free Cash Flow Per Share | -20.99 | -24.25 | -21.48 | -31.30 | -34.16 | -56.59 |
| Levered Free Cash Flow | -9.71M | -6.20M | -3.11M | -5.08M | 6.15M | 5.70M |
| Unlevered Free Cash Flow | -9.71M | -6.20M | -3.11M | -5.08M | 6.15M | 5.71M |
| Cash Interest Paid | 983.00 | |||||
| Change in Working Capital | 570.88K | 1.31M | 28.65K | 515.33K | 14.14K | 324.69K |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 1.89M | 10.43M | 9.90M | 8.19M | 10.10M | 15.16M |
| Enterprise Value | -1.68M | 5.95M | -3.14M | -3.84M | -6.04M | 20.37M |
| Last Close Price | 1.48 | 23.50 | 28.60 | 34.80 | 55.00 | 86.80 |
| PS Ratio | 5.27 | 29.00 | 24.68 | 56.17 | 84.33 | 329.56 |
| PB Ratio | 0.62 | 29.23 | 1.16 | 0.82 | 0.98 | 0.70 |
| P/TBV Ratio | 0.75 | 1.25 | 0.88 | 1.07 | 0.72 | |
| EV/Sales Ratio | 16.55 | 442.81 | ||||
| Debt / Equity Ratio | 0.01 | 0.12 | 0.02 | 0.03 | 0.03 | |
| Net Debt / Equity Ratio | -1.18 | -8.16 | -1.26 | -1.09 | -1.40 | -0.94 |
| Net Debt / EBITDA Ratio | 0.25 | 0.19 | 0.94 | 0.72 | 0.77 | 0.78 |
| Net Debt / FCF Ratio | 0.30 | 0.27 | 1.29 | 1.65 | 2.34 | 6.06 |
| Asset Turnover | 0.05 | 0.04 | 0.03 | 0.01 | 0.01 | 0.00 |
| Quick Ratio | 2.23 | 0.80 | 2.91 | 4.25 | 2.47 | 57.81 |
| Current Ratio | 2.35 | 0.84 | 2.97 | 4.37 | 2.53 | 59.01 |
| Return on Equity (ROE) | -241.14% | -320.47% | -96.89% | -102.66% | -82.93% | -437.23% |
| Return on Assets (ROA) | -118.81% | -119.56% | -58.03% | -65.50% | -60.99% | -122.70% |
| Return on Capital Employed (ROCE) | -470.20% | -4,386.10% | -135.40% | -152.10% | -181.50% | -119.10% |
| Earnings Yield | -1,318.07% | -136.55% | -90.74% | -127.21% | -130.88% | -292.25% |
| FCF Yield | -631.05% | -104.56% | -84.25% | -80.61% | -61.16% | -22.17% |
| Buyback Yield / Dilution | -38.49% | -15.83% | -84.05% | -16.60% | -204.60% | -200.92% |